Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pyoderma

• Spesolimab in Pyoderma Gangrenosum
• Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum
• Deucravacitinib in PG
• Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma
• Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum
• Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
• Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum
• Exploratory Study of IFX-1 in Subjects With Pyoderma Gangrenosum
• A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan
• Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum
• Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum
• An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
• A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum
• An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
• Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum
• Canakinumab for Pyoderma Gangrenosum
• Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
• Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum
• Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum
• Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)